世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

オミックスベースの臨床試験の世界市場規模調査、フェーズ別(フェーズI、フェーズII、フェーズIII、フェーズIV)、試験デザイン別(介入試験、観察試験、拡大アクセス試験)、適応症別(腫瘍、循環器、呼吸器、皮膚、中枢神経、免疫、遺伝子疾患(希少疾患含む)、その他(眼科、耳疾患含む))と地域予測2022-2028年


Global Omics-Based Clinical Trials Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases (includes the rare diseases), Others (includes ophthalmic, ear diseases)) and Regional Forecasts 2022-2028

オミックスベースの臨床試験の世界市場は、2021年に約244億米ドルと評価され、予測期間2022-2028年には7.4%以上の健全な成長率で成長すると予想されています。オミックスベースの臨床試験は、ゲノミクス、メタボ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2022年4月22日 US$4,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

オミックスベースの臨床試験の世界市場は、2021年に約244億米ドルと評価され、予測期間2022-2028年には7.4%以上の健全な成長率で成長すると予想されています。オミックスベースの臨床試験は、ゲノミクス、メタボロミクス、エピゲノミクス、プロテオミクスなどに関連した患者の臨床分析に使用されます。慢性疾患の増加により、予測期間中、オミックスベースの臨床試験の採用が進んでいます。例えば2021年の米国疾病管理予防センターによると、慢性疾患の患者数と死亡者数は急速に増加しています。糖尿病の患者数は2億8,500万人で、これは世界の総成人人口の約6.4%に相当します。製薬会社による投資の増加は、オミックスベースの臨床試験市場の成長を後押ししています。また、臨床試験におけるオミックスアプローチの需要の増加により、オミックスベースの臨床試験の採用や需要は予測期間中に市場成長を高めると思われます。しかし、臨床試験のコスト上昇は、2022-2028年の予測期間における市場成長の妨げとなる。

オミックスベースの臨床試験の世界市場分析で考慮した地理的地域は、アジア太平洋、北米、ヨーロッパ、ラテンアメリカ、その他の地域です。北米は、慢性疾患の症例数の増加、主要プレイヤーの存在、医療の進歩に向けた投資の増加により、巨大な市場シェアの点で世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の間に最大の成長率を達成すると推定されています。臨床試験における研究開発の増加や、ヘルスケア部門に対する政府支出の増加といった要因が、アジア太平洋地域のオミックスベースの臨床試験市場に有益な成長予測を生み出すと考えられます。

本レポートに含まれる主な市場関係者は以下の通りです。
パレクセル・インターナショナル・コーポレーション
ファーマシューティカル・プロダクト・ディベロップメント (PPD)
チャールズリバーラボラトリー
ICON plc
SGS SA
イーライリリー・アンド・カンパニー
ファイザー株式会社
コバンス社
ノボノルディスク
リーバス・バイオ

本調査の目的は、近年における様々なセグメント&国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、調査対象となる各地域および各国における産業の質的および量的な側面を取り込むよう設計されています。さらに、市場の将来的な成長を規定する駆動因子や課題などの重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場で利用可能な機会も組み込まなければなりません。市場の詳細なセグメントとサブセグメントを以下に説明します。
フェーズ別
フェーズI
フェーズII
フェーズIII
フェーズIV
研究デザイン別
介入研究
観察研究(Observational Studies
エクスパンデッドアクセススタディ
適応症別
オンコロジー
循環器領域
呼吸器領域
皮膚疾患
中枢神経系
免疫学
遺伝性疾患(希少疾病を含む)
その他(眼科疾患、耳鼻咽喉科疾患など)
地域別
北米
米国
カナダ
欧州
英国
ドイツ
フランス
スペイン
イタリア
ROE

アジア太平洋地域
中国
インド
日本
オーストラリア
韓国
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

さらに、調査のために考慮した年は以下の通りです。

過去年 - 2018年,2019年,2020年
基準年 - 2021年
予測期間 - 2022年~2028年

市場調査における世界のオミックスベースの臨床試験市場の対象読者

主要なコンサルティング会社およびアドバイザー
大企業、中堅企業、中小企業
ベンチャーキャピタル
付加価値再販業者(VAR)
サードパーティー・ナレッジ・プロバイダー
投資銀行家
投資家


ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion)
1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion)
1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion)
1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Omics-Based Clinical Trials Market Dynamics
3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing incidences of chronic diseases
3.1.1.2. Increasing investment by pharmaceutical companies
3.1.2. Market Challenges
3.1.2.1. Higher cost of clinical trials
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for omics approaches for clinical trials
Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Omics-Based Clinical Trials Market, by Phase
6.1. Market Snapshot
6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis
6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion)
6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
6.4.1. Phase I
6.4.2. Phase II
6.4.3. Phase III
6.4.4. Phase IV
Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design
7.1. Market Snapshot
7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis
7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion)
7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
7.4.1. Interventional Studies
7.4.2. Observational Studies
7.4.3. Expanded Access Studies
Chapter 8. Global Omics-Based Clinical Trials Market, by Indication
8.1. Market Snapshot
8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis
8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Cardiology
8.4.3. Respiratory Diseases
8.4.4. Skin Diseases
8.4.5. CNS Diseases
8.4.6. Immunology
8.4.7. Genetic Diseases (includes the rare diseases)
8.4.8. Others (includes ophthalmic, ear diseases, etc)
Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis
9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot
9.2. North America Omics-Based Clinical Trials Market
9.2.1. U.S. Omics-Based Clinical Trials Market
9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028
9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028
9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028
9.2.2. Canada Omics-Based Clinical Trials Market
9.3. Europe Omics-Based Clinical Trials Market Snapshot
9.3.1. U.K. Omics-Based Clinical Trials Market
9.3.2. Germany Omics-Based Clinical Trials Market
9.3.3. France Omics-Based Clinical Trials Market
9.3.4. Spain Omics-Based Clinical Trials Market
9.3.5. Italy Omics-Based Clinical Trials Market
9.3.6. Rest of Europe Omics-Based Clinical Trials Market
9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot
9.4.1. China Omics-Based Clinical Trials Market
9.4.2. India Omics-Based Clinical Trials Market
9.4.3. Japan Omics-Based Clinical Trials Market
9.4.4. Australia Omics-Based Clinical Trials Market
9.4.5. South Korea Omics-Based Clinical Trials Market
9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market
9.5. Latin America Omics-Based Clinical Trials Market Snapshot
9.5.1. Brazil Omics-Based Clinical Trials Market
9.5.2. Mexico Omics-Based Clinical Trials Market
9.6. Rest of The World Omics-Based Clinical Trials Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Parexel International Corporation
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Pharmaceutical Product Development (PPD)
10.2.3. Charles River Laboratory
10.2.4. ICON plc
10.2.5. SGS SA
10.2.6. Eli Lilly and Company
10.2.7. Pfizer Inc.
10.2.8. Covance Inc.
10.2.9. Novo Nordisk
10.2.10. Rebus Bio
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption


List of Tables
TABLE 1. Global Omics-Based Clinical Trials market, report scope
TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion)
TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion)
TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion)
TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market
TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

 

ページTOPに戻る


 

Summary

Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4 % over the forecast period 2022-2028. Omics-Based Clinical Trials are used for the clinical analysis of patients related to genomics, metabolomics epigenomics, proteomics etc. The growing incidences of chronic diseases have led to the adoption of Omics-Based Clinical Trials across the forecast period. For Instance: According to the Centers for Disease Control and Prevention in 2021, the number of cases and deaths by chronic diseases is increasing rapidly. The diabetic cases with illness have affected 285 million people which is equivalent to about 6.4 % of the total adult population globally. Increasing investment by pharmaceutical companies pushes the market growth of omics-based clinical trials. Also, with the increasing demand for omics approaches for clinical trials, the adoption & demand for Omics-Based Clinical Trials is likely to increase the market growth during the forecast period. However, higher costs of clinical trials impede the growth of the market over the forecast period of 2022-2028.

The geographical regions considered for the global Omics-Based Clinical Trials market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of huge market share due to the increasing cases of chronic disorders, presence of key players and growing investment towards the advancement of healthcare. Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during 2022-2028. Factors such as increasing R&D in clinical trials and increasing government expenditure towards the healthcare sector would create beneficial growth forecasts for the Omics-Based Clinical Trials market across Asia-Pacific region.

Major market players included in this report are:
Parexel International Corporation
Pharmaceutical Product Development (PPD)
Charles River Laboratory
ICON plc
SGS SA
Eli Lilly and Company
Pfizer Inc.
Covance Inc.
Novo Nordisk
Rebus Bio

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Phase:
Phase I
Phase II
Phase III
Phase IV
By Study Design:
Interventional Studies
Observational Studies
Expanded Access Studies
By Indication:
Oncology
Cardiology
Respiratory Diseases
Skin Diseases
CNS Diseases
Immunology
Genetic Diseases (includes the rare diseases)
Others (includes ophthalmic, ear diseases, etc)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019,2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Omics-Based Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion)
1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion)
1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion)
1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Omics-Based Clinical Trials Market Dynamics
3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing incidences of chronic diseases
3.1.1.2. Increasing investment by pharmaceutical companies
3.1.2. Market Challenges
3.1.2.1. Higher cost of clinical trials
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for omics approaches for clinical trials
Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Omics-Based Clinical Trials Market, by Phase
6.1. Market Snapshot
6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis
6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion)
6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
6.4.1. Phase I
6.4.2. Phase II
6.4.3. Phase III
6.4.4. Phase IV
Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design
7.1. Market Snapshot
7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis
7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion)
7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
7.4.1. Interventional Studies
7.4.2. Observational Studies
7.4.3. Expanded Access Studies
Chapter 8. Global Omics-Based Clinical Trials Market, by Indication
8.1. Market Snapshot
8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis
8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Cardiology
8.4.3. Respiratory Diseases
8.4.4. Skin Diseases
8.4.5. CNS Diseases
8.4.6. Immunology
8.4.7. Genetic Diseases (includes the rare diseases)
8.4.8. Others (includes ophthalmic, ear diseases, etc)
Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis
9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot
9.2. North America Omics-Based Clinical Trials Market
9.2.1. U.S. Omics-Based Clinical Trials Market
9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028
9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028
9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028
9.2.2. Canada Omics-Based Clinical Trials Market
9.3. Europe Omics-Based Clinical Trials Market Snapshot
9.3.1. U.K. Omics-Based Clinical Trials Market
9.3.2. Germany Omics-Based Clinical Trials Market
9.3.3. France Omics-Based Clinical Trials Market
9.3.4. Spain Omics-Based Clinical Trials Market
9.3.5. Italy Omics-Based Clinical Trials Market
9.3.6. Rest of Europe Omics-Based Clinical Trials Market
9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot
9.4.1. China Omics-Based Clinical Trials Market
9.4.2. India Omics-Based Clinical Trials Market
9.4.3. Japan Omics-Based Clinical Trials Market
9.4.4. Australia Omics-Based Clinical Trials Market
9.4.5. South Korea Omics-Based Clinical Trials Market
9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market
9.5. Latin America Omics-Based Clinical Trials Market Snapshot
9.5.1. Brazil Omics-Based Clinical Trials Market
9.5.2. Mexico Omics-Based Clinical Trials Market
9.6. Rest of The World Omics-Based Clinical Trials Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Parexel International Corporation
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Pharmaceutical Product Development (PPD)
10.2.3. Charles River Laboratory
10.2.4. ICON plc
10.2.5. SGS SA
10.2.6. Eli Lilly and Company
10.2.7. Pfizer Inc.
10.2.8. Covance Inc.
10.2.9. Novo Nordisk
10.2.10. Rebus Bio
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption


List of Tables
TABLE 1. Global Omics-Based Clinical Trials market, report scope
TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion)
TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion)
TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion)
TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market
TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(薬学的薬物)の最新刊レポート

Bizwit Research & Consulting LLP社のその他分野での最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る